Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma

Saved in:
Bibliographic Details
Published in:Journal of Clinical and Experimental Hematopathology 2019, Vol.59(2), pp.98-100
Main Authors: Maruyama, Dai, Nagai, Hirokazu, Fukuhara, Noriko, Kitano, Toshiyuki, Ishikawa, Takayuki, Nishikawa, Tomoaki
Format: Article
Language:English
Subjects:
covalent BTK inhibitor
ibrutinib
Japanese patients
Letter to the Editor
mantle cell lymphoma
phase II clinical trial
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1346-4280
1880-9952
DOI:10.3960/jslrt.19006